Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ('Bluejay” or the 'Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 ...

Two complementary studies reveal how an insufficient supply of energy in macrophages, key immune cells in artery walls, ...

PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC, a leader in Lab-on-a-Chip non-invasive Point-of-Care diagnostics—today announced that it has received a ...

The closing of the private placement is expected to occur on or about January 2, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the ...

Paramount Business Jets reports that by 2030, many safety features in private aviation likely will shift from optional to ...

Renewed and extended partnerships underline a commitment to inclusive sport, faster access to care, and innovation across the ...

And that was just in the first six months. By catching needed radiology follow-ups and ensuring patients receive recommended ...

As South Africa accelerates its energy transition, a gap is opening between financial planning and physical reality. Gillian ...

Foreign vloggers praise China’s healthcare for speed, low cost and accessibility, citing efficient public hospitals and nationwide reforms.

India’s fruit and vegetable crops are often plagued with pathogens and substandard farm practices. The University of Arkansas ...

Shareholders approved a reverse stock split range of 1-for-2 to 1-for-30 at a special meeting on December 5. ・Split-adjusted ...

Learn more about whether AtriCure, Inc. or Baxter International Inc. is a better investment based on AAII's A+ Investor ...